{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:25:48Z","timestamp":1760955948227},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jns.2019.05.023","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:50:48Z","timestamp":1558612248000},"page":"162-166","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effect of direct oral anticoagulant for acute major cerebral artery occlusion in cardioembolic stroke\/transient ischemic attack patients with non-valvular atrial fibrillation"],"prefix":"10.1016","volume":"402","author":[{"given":"Shinya","family":"Tomari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junnosuke","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Sata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikuzo","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoaki","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jns.2019.05.023_bb0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.STR.28.2.311","article-title":"Atrial fibrillation and stroke. Mortality and causes of death after the first acute ischemic stroke","volume":"28","author":"Kaarisalo","year":"1997","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jns.2019.05.023_bb0010","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jnnp.2004.048827","article-title":"Japan Multicenter Stroke Investigators C. Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke","volume":"76","author":"Kimura","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.jns.2019.05.023_bb0015","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/STROKEAHA.116.012865","article-title":"Atrial fibrillation is associated with a worse 90-day outcome than other cardioembolic stroke subtypes","volume":"47","author":"Henninger","year":"2016","journal-title":"Stroke"},{"issue":"20","key":"10.1016\/j.jns.2019.05.023_bb0020","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1001\/archinte.1995.00430200078011","article-title":"Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation","volume":"155","author":"Manning","year":"1995","journal-title":"Arch. Intern. Med."},{"issue":"13","key":"10.1016\/j.jns.2019.05.023_bb0025","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Analysis of pooled data from five randomized controlled trials","volume":"154","author":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation","year":"1994","journal-title":"Arch. Intern. Med."},{"issue":"7","key":"10.1016\/j.jns.2019.05.023_bb0030","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","article-title":"Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis","volume":"131","author":"Hart","year":"1999","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.jns.2019.05.023_bb0035","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.21456","article-title":"Admission international normalized ratio and acute infarct volume in ischemic stroke","volume":"64","author":"Ay","year":"2008","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2019.05.023_bb0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000332037","article-title":"Preadmission therapeutic anticoagulation reduces cerebral infarct volume in patients with nonvalvular atrial fibrillation","volume":"66","author":"Matsumoto","year":"2011","journal-title":"Eur. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2019.05.023_bb0045","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.jns.2019.05.023_bb0050","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1474-4422(06)70536-1","article-title":"Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study","volume":"5","author":"O'Donnell","year":"2006","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.jns.2019.05.023_bb0055","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.jns.2019.05.023_bb0060","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.jns.2019.05.023_bb0065","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.jns.2019.05.023_bb0070","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jns.2019.05.023_bb0075","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.004","article-title":"Severity and Functional Outcome of Patients with Cardioembolic Stroke Occurring during Non-vitamin K Antagonist Oral Anticoagulant Treatment","volume":"24","author":"Tomita","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"4","key":"10.1016\/j.jns.2019.05.023_bb0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11239-018-1634-1","article-title":"Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke","volume":"45","author":"Hoyer","year":"2018","journal-title":"J. Thromb. Thrombolysis"},{"issue":"4","key":"10.1016\/j.jns.2019.05.023_bb0085","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/europace\/eux087","article-title":"Non-vitamin K-dependent oral anticoagulants have a positive impact on ischaemic stroke severity in patients with atrial fibrillation","volume":"20","author":"Hellwig","year":"2018","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.jns.2019.05.023_bb0090","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.05.009","article-title":"Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era","volume":"22","author":"Endo","year":"2013","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"9","key":"10.1016\/j.jns.2019.05.023_bb0095","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1253\/circj.CJ-13-0290","article-title":"Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation: results of the J-RHYTHM Registry","volume":"77","author":"Inoue","year":"2013","journal-title":"Circ. J."},{"issue":"4","key":"10.1016\/j.jns.2019.05.023_bb0100","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1160\/TH15-08-0631","article-title":"Pretreatment with rivaroxaban attenuates stroke severity in rats by a dual antithrombotic and anti-inflammatory mechanism","volume":"115","author":"Dittmeier","year":"2016","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.jns.2019.05.023_bb0105","first-page":"238","article-title":"Relationships between angiographic findings and National Institutes of Health stroke scale score in cases of hyperacute carotid ischemic stroke","volume":"25","author":"Nakajima","year":"2004","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"10","key":"10.1016\/j.jns.2019.05.023_bb0110","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/01.STR.0000182099.04994.fc","article-title":"NIHSS score and arteriographic findings in acute ischemic stroke","volume":"36","author":"Fischer","year":"2005","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jns.2019.05.023_bb0115","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann. Thorac. Surg."},{"issue":"11","key":"10.1016\/j.jns.2019.05.023_bb0120","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1253\/circj.CJ-18-0398","article-title":"Left atrial appendage thrombus prior to atrial fibrillation ablation in the era of direct oral anticoagulants","volume":"82","author":"Harada","year":"2018","journal-title":"Circ. J."},{"key":"10.1016\/j.jns.2019.05.023_bb0125","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ahj.2016.05.007","article-title":"Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)","volume":"178","author":"Lip","year":"2016","journal-title":"Am. Heart J."},{"issue":"3","key":"10.1016\/j.jns.2019.05.023_bb0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.joa.2016.01.009","article-title":"Resolution of a warfarin and dabigatran-resistant left atrial appendage thrombus with apixaban","volume":"32","author":"Miwa","year":"2016","journal-title":"J. Arrhythm."},{"issue":"10","key":"10.1016\/j.jns.2019.05.023_bb0135","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.07.036","article-title":"Resolving thrombus in the left atrial appendage by edoxaban treatment after acute ischemic stroke: report of 2 cases","volume":"25","author":"Saito","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"4","key":"10.1016\/j.jns.2019.05.023_bb0140","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1160\/TH12-11-0821","article-title":"Resolution of giant left atrial appendage thrombus with rivaroxaban","volume":"109","author":"Hammerstingl","year":"2013","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.jns.2019.05.023_bb0145","first-page":"807","article-title":"Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants","volume":"13","author":"Garkina","year":"2016","journal-title":"J. Geriatr. Cardiol."},{"key":"10.1016\/j.jns.2019.05.023_bb0150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.thromres.2017.12.021","article-title":"Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching study","volume":"162","author":"Bartoli-Abdou","year":"2018","journal-title":"Thromb. Res."},{"issue":"24","key":"10.1016\/j.jns.2019.05.023_bb0155","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.jacc.2016.09.966","article-title":"Off-Label dosing of non-vitamin k antagonist oral anticoagulants and adverse outcomes: the ORBIT-AF II registry","volume":"68","author":"Steinberg","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.jns.2019.05.023_bb0160","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jacc.2017.03.609","article-title":"Inconsistent dosing of non-vitamin k oral anticoagulants: differences between the United States and Japan","volume":"70","author":"Ono","year":"2017","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19302394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19302394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T18:08:57Z","timestamp":1560362937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X19302394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":32,"alternative-id":["S0022510X19302394"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.05.023","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of direct oral anticoagulant for acute major cerebral artery occlusion in cardioembolic stroke\/transient ischemic attack patients with non-valvular atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}